VIR — VIR BIOTECHNOLOGY INC

Ownership history in GSK plc  ·  1 quarter on record

This page tracks every 13F SEC filing in which GSK plc reported a position in VIR BIOTECHNOLOGY INC (VIR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
6.45% (2025 Q4)
Avg. % of fund
6.45%
First filed
2025 Q4
Last filed
2025 Q4
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 INITIATED 8,550,954 — — 6.45% $51.6M $6.03
% of Fund (quarterly)    VIR price (monthly, adj. close)

Other funds also holding VIR

As of 2025 Q4 — sorted by position size

ARCH Venture Management, LLC 3Y 7Y 11.95% GordonMD Global Investments LP 4.02% SB INVESTMENT ADVISERS (UK) LTD 3Y 7Y 0.79% Sio Capital Management, LLC 3Y 7Y 0.45% Tejara Capital Ltd 3Y 0.33% Eagle Health Investments LP 3Y 0.32% ORBIMED ADVISORS LLC 3Y 7Y 0.29% Ikarian Capital, LLC 3Y 0.27% Clarius Group, LLC 3Y 7Y 0.21% Persistent Asset Partners Ltd 0.17%
← Back to GSK plc Holdings